Lung HIV Microbiome Project (Michigan Site)
NCT02392182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59
Last updated 2016-09-16
Summary
In its original phase, this cohort study recruited subjects who were either HIV-positive or HIV-negative healthy controls, to analyze the community structure of the lung microbiome. Original recruitment was planned to occur both at the University of Michigan Medical Center and clinics, and at VA Ann Arbor Healthcare System.
Enrollment for the original cohort is completed, and all current activity of this project is occurring at VA Ann Arbor, where both Veteran subjects and non-Veteran subjects are eligible to participate. This study is currently recruiting only healthy HIV-negative subjects. Participation, described below, involves a research bronchoscopy procedure.
Conditions
- Healthy Participants
- Tobacco Use Disorder
- Human Microbiome
Interventions
- OTHER
-
Fiberoptic bronchoscopy
All subjects will undergo a research fiberoptic bronchoscopy under moderate conscious sedation. There is no randomization
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jeffrey L. Curtis, MD · Professor of Internal Medicine & Staff Physician, VA Ann Arbor
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
Countries
- United States
Study Locations
More Related Trials
-
Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung Disease
NCT02058719 ·Status: COMPLETED
-
Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study
NCT01207986 ·Status: COMPLETED ·Phase: NA
-
Pneumocystis in Pathogenesis of HIV-associated Emphysema
NCT00869544 ·Status: COMPLETED
-
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
NCT02238327 ·Status: COMPLETED
-
Acute HIV Infection Observational Study
NCT00296660 ·Status: COMPLETED
-
Lung HIV Disease in a Large Cohort-Pitt
NCT01326572 ·Status: COMPLETED
-
Evaluation and Monitoring of Patients With HIV Infectionn
NCT00557570 ·Status: COMPLETED
-
Analysis of the Nasal Mucosal Immune Response in HIV Infection
NCT03920709 ·Status: UNKNOWN
-
Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)
NCT00933595 ·Status: COMPLETED ·Phase: NA
-
Examining Factors That May Influence Resistance to HIV-1 Infection
NCT00351442 ·Status: COMPLETED
-
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
NCT01212042 ·Status: TERMINATED
-
Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis
NCT07146529 ·Status: NOT_YET_RECRUITING
-
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
NCT00789009 ·Status: RECRUITING
-
A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
NCT00001121 ·Status: COMPLETED
-
Diet / Gut Microbiome Interaction and Influence on Inflammatory Disease in HIV Patients
NCT02610374 ·Status: COMPLETED ·Phase: NA
-
Impact of ART Adherence on HIV Persistence and Inflammation
NCT02797093 ·Status: COMPLETED
-
A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection
NCT00005572 ·Status: COMPLETED
-
Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients
NCT02116374 ·Status: COMPLETED
-
A Study of the Long-Term Outcomes of HIV-Positive Patients
NCT00000932 ·Status: COMPLETED
-
Adiposity and Airway Inflammation in HIV-Associated Airway Disease
NCT02975258 ·Status: COMPLETED
-
The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
NCT00857350 ·Status: COMPLETED
-
Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center
NCT00870857 ·Status: COMPLETED
-
Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
NCT02012621 ·Status: COMPLETED
-
Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients
NCT02405026 ·Status: COMPLETED
-
Treatment of Acute HIV Infection to Preserve Immune Function
NCT00055094 ·Status: COMPLETED